AngioDynamics to Report Fiscal 2025 Third Quarter Financial Results on April 2, 2025 and Host Virtual Cardiovascular Investor Event
AngioDynamics (NASDAQ: ANGO), a medical technology company specializing in vascular health and cancer treatment, has announced its upcoming fiscal 2025 third quarter financial results release scheduled for April 2, 2025, before market open.
The company will host two key events on the same day: a financial results conference call at 8:00 AM ET, followed by a virtual cardiovascular investor event at 9:00 AM ET. The latter will provide an in-depth look at the company's cardiovascular technology portfolio and strategic vision.
Investors can participate in the conference call through domestic (1-877-407-0784) or international (+1-201-689-8560) dial-in numbers. Both events will be accessible via webcast through the company's investor relations website. A replay of the call will be available until April 09, 2025, using passcode 13752371.
AngioDynamics (NASDAQ: ANGO), un'azienda di tecnologia medica specializzata nella salute vascolare e nel trattamento del cancro, ha annunciato il rilascio dei risultati finanziari del terzo trimestre dell'esercizio fiscale 2025, previsto per 2 aprile 2025, prima dell'apertura del mercato.
L'azienda ospiterà due eventi chiave lo stesso giorno: una conference call sui risultati finanziari alle 8:00 AM ET, seguita da un evento virtuale per investitori nel campo cardiovascolare alle 9:00 AM ET. Quest'ultimo fornirà uno sguardo approfondito sul portafoglio tecnologico cardiovascolare dell'azienda e sulla sua visione strategica.
Gli investitori possono partecipare alla conference call tramite numeri di accesso nazionali (1-877-407-0784) o internazionali (+1-201-689-8560). Entrambi gli eventi saranno accessibili tramite webcast sul sito web delle relazioni con gli investitori dell'azienda. Una registrazione della chiamata sarà disponibile fino al 9 aprile 2025, utilizzando il codice di accesso 13752371.
AngioDynamics (NASDAQ: ANGO), una empresa de tecnología médica especializada en salud vascular y tratamiento del cáncer, ha anunciado la publicación de sus resultados financieros del tercer trimestre del ejercicio fiscal 2025, programada para el 2 de abril de 2025, antes de la apertura del mercado.
La compañía llevará a cabo dos eventos clave el mismo día: una llamada de conferencia sobre resultados financieros a las 8:00 AM ET, seguida de un evento virtual para inversores en el área cardiovascular a las 9:00 AM ET. Este último ofrecerá una visión detallada del portafolio de tecnología cardiovascular de la empresa y su visión estratégica.
Los inversores pueden participar en la llamada de conferencia a través de números de acceso nacionales (1-877-407-0784) o internacionales (+1-201-689-8560). Ambos eventos serán accesibles a través de una transmisión web en el sitio web de relaciones con inversores de la empresa. Una grabación de la llamada estará disponible hasta el 9 de abril de 2025, utilizando el código de acceso 13752371.
AngioDynamics (NASDAQ: ANGO), 혈관 건강 및 암 치료를 전문으로 하는 의료 기술 회사는 2025년 4월 2일에 시장 개장 전 발표될 2025 회계연도 3분기 재무 결과를 발표했습니다.
회사는 같은 날 두 가지 주요 이벤트를 개최합니다: 오전 8시 ET에 재무 결과 컨퍼런스 콜이 진행되며, 이어서 오전 9시 ET에 가상 심혈관 투자자 이벤트가 진행됩니다. 후자는 회사의 심혈관 기술 포트폴리오와 전략적 비전에 대한 심층적인 통찰을 제공합니다.
투자자들은 국내 전화번호(1-877-407-0784) 또는 국제 전화번호(+1-201-689-8560)를 통해 컨퍼런스 콜에 참여할 수 있습니다. 두 이벤트 모두 회사의 투자자 관계 웹사이트를 통해 웹캐스트로 접근할 수 있습니다. 통화의 재생은 2025년 4월 9일까지 사용할 수 있으며, 비밀번호는 13752371입니다.
AngioDynamics (NASDAQ: ANGO), une entreprise de technologie médicale spécialisée dans la santé vasculaire et le traitement du cancer, a annoncé la publication de ses résultats financiers du troisième trimestre de l'exercice fiscal 2025, prévue pour le 2 avril 2025, avant l'ouverture du marché.
L'entreprise organisera deux événements clés le même jour : une conférence téléphonique sur les résultats financiers à 8h00 ET, suivie d'un événement virtuel pour les investisseurs dans le domaine cardiovasculaire à 9h00 ET. Ce dernier offrira un aperçu approfondi du portefeuille technologique cardiovasculaire de l'entreprise et de sa vision stratégique.
Les investisseurs peuvent participer à la conférence téléphonique via des numéros d'appel nationaux (1-877-407-0784) ou internationaux (+1-201-689-8560). Les deux événements seront accessibles par webcast via le site web des relations avec les investisseurs de l'entreprise. Un enregistrement de l'appel sera disponible jusqu'au 9 avril 2025, en utilisant le code d'accès 13752371.
AngioDynamics (NASDAQ: ANGO), ein Medizintechnikunternehmen, das sich auf vaskuläre Gesundheit und Krebsbehandlung spezialisiert hat, hat die Veröffentlichung seiner finanziellen Ergebnisse für das dritte Quartal des Geschäftsjahres 2025 angekündigt, die für den 2. April 2025 vor Markteröffnung geplant ist.
Das Unternehmen wird am selben Tag zwei wichtige Veranstaltungen ausrichten: eine Telefonkonferenz zu den Finanzergebnissen um 8:00 AM ET, gefolgt von einer virtuellen Investorenveranstaltung im Bereich der Kardiologie um 9:00 AM ET. Letzteres wird einen detaillierten Einblick in das kardiovaskuläre Technologieportfolio des Unternehmens und seine strategische Vision geben.
Investoren können an der Telefonkonferenz über nationale (1-877-407-0784) oder internationale (+1-201-689-8560) Einwahlnummern teilnehmen. Beide Veranstaltungen sind über ein Webcast auf der Investor Relations-Website des Unternehmens zugänglich. Eine Wiederholung des Anrufs wird bis zum 9. April 2025 verfügbar sein, mit dem Zugangscode 13752371.
- None.
- None.
Fiscal 2025 Third Quarter Financial Results Conference Call
The Company’s management will host a conference call at 8:00 am ET the same day to discuss the results.
To participate in the conference call, dial 1-877-407-0784 (domestic) or +1-201-689-8560 (international).
This conference call will also be webcast and can be accessed from the “Investors” section of the AngioDynamics website at www.angiodynamics.com. The webcast replay of the call will be available at the same site approximately one hour after the end of the call.
A recording of the call will also be available, until Wednesday, April 09, 2025 at 11:59 PM ET. To hear this recording, dial 1-844-512-2921 (domestic) or +1-412-317-6671 (international) and enter the passcode 13752371.
Virtual Cardiovascular Investor Event
AngioDynamics will host a virtual investor event on April 2, 2025 at 9:00am to provide investors a deeper dive into the cardiovascular technology portfolio and strategic vision.
The event will be webcast and can be accessed through the "Investors" section of the AngioDynamics website at www.angiodynamics.com.
About AngioDynamics, Inc.
AngioDynamics is a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving quality of life for patients.
The Company’s innovative technologies and devices are chosen by talented physicians in fast-growing healthcare markets to treat unmet patient needs. For more information, visit www.angiodynamics.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250319101713/en/
Investors:
AngioDynamics, Inc.
Stephen Trowbridge, Executive Vice President & CFO
(518) 795-1408
Source: AngioDynamics, Inc.
FAQ
When will AngioDynamics (ANGO) release its Q3 fiscal 2025 earnings?
What time is AngioDynamics' Q3 2025 earnings call?
How can investors access ANGO's cardiovascular investor event on April 2, 2025?
Until when will ANGO's Q3 2025 earnings call replay be available?
